Preventive Effect of the PRetreatment With Intravenous Nicorandil on Contrast-Induced Nephropathy in Patients With RenaL Dysfunction UndEergoing Coronary Angiography (PRINCIPLE Study)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 173 participants.

Also called NCT01103336

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 173 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01103336
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01103336. Randomized; no masking; primary purpose prevention. Start 2010-03 (registry gives no type); primary completion 2011-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Preventive Effect of the PRetreatment With Intravenous Nicorandil on Contrast-Induced Nephropathy in Patients With RenaL Dysfunction UndEergoing Coronary Angiography (PRINCIPLE Study)
Condition
Chronic Renal Failure
Intervention (Drug)
pretreatment with intravenous nicorandil vs. placebo before coronary angiography
Lead sponsor
Yonsei University (class: other)
Collaborator
GE Healthcare (class: industry)

Record details

Record id
cardio:ct-nct01103336
Content hash
d3c208958b5998e5efd260bad548e709b614b240862997d22ead6cd9011d3270